The Clinell Training Package has taken ‘Best educational app’ in the Best Mobile App awards. Developed in conjunction with some of the leading infection prevention and control (IPC) specialists in the UK, the Clinell Training Package is a tablet-based software package designed to arm infection prevention professionals with the very best tools in their fight against healthcare associated infections.
From advanced audit tools to simple games, the Clinell Training Package offers the most comprehensive IPC educational software suite available. Every training package a UV marker for effective auditing of cleanliness; the use of fluorescent marker mimics the microbiological data more accurately than other systems (such as ATP bioluminescence)1 and use of a UV marker system in an ICU resulted in 40% more surfaces being cleaned2. It also comes with a 50-page ‘Protecting the Patient’ supporting document that provides a thorough review of the latest clinical and scientific evidence.
The Clinell Training Package allows infection prevention specialists to make better, more informed decisions. It frees them up to spend more time engaging with staff and advocating evidence-based policy. Most importantly, the Clinell Training Package helps ensure every patient gets safe, effective healthcare.
The Clinell Training Package is available free* to acute healthcare customers, speak to your area manager to make sure you get access to your award-winning Training Package.
1 Rutala WA, Gergen MF, Sickbert-Bennett E, Huslage K, Weber DJ. Comparison of four methods to assess cleanliness. APIC; Fort Lauderdale 2013.
2 Carling PC, Parry MF, Bruno-Murtha LA, Dick B. Improving environmental hygiene in 27 intensive care units to decrease multidrug-resistant bacterial transmission. Critical care medicine. 2010;38(4):1054-9.
* Subject to minimum spend.
Building on the research collaboration with the College of Nursing, Midwifery and Healthcare at the University of West London, GAMA Healthcare is providing scholarship opportunities to candidates studying a Postgraduate Diploma in Advanced Practice (Infection Prevention & Control).
The course is open to those currently working in the field and is an excellent stepping stone for IPC professionals looking to further their career. Commencing October 2017, for two applicants per year, GAMA will fully finance the tuition fees for the 2-year Postgraduate Diploma. At the end, students will either receive the standalone PG-Dip, or, complete a 3rd year at their own expense to convert to a full MSc. Further details about the course can be found by following this link.
Applicants must complete their first stage application with UWL (details of how to do so can be found on the UWL website) and then complete a GAMA IP Scholarship Award application form from either Dr Jennie Wilson (email@example.com) or by downloading from the button below before the 31st of August deadline. Successful applicants will be notified by the 21st of September.
Collaboration between UWL and GAMA Healthcare will help develop the careers of the next leading lights of the infection prevention & control community. The skills and experiences they develop here will shape infection prevention policies of the future and help win the fight against healthcare associated infections.
Any questions regarding the application process should be directed towards Dr Jennie Wilson (firstname.lastname@example.org)
Apply and fill out our application form below before the
31st of August
GAMA IP Scholarship Award Form
The Therapeutic Goods Administration (TGA) recently published a Medical Devices Safety Update (vol. 5, no. 3, May 2017) which contained an article entitled ‘Disinfectants and detergents can damage medical equipment plastics’. GAMA Healthcare are aware that this has caused a lot of concern and confusion in the Australian marketplace.
We welcome the publication of the following clarifications to the alert which is now available to view on the TGA website:
i. Certain disinfectant wipes and detergents can damage medical devices if the cleaning agent is incompatible with the device’s plastic surfaces*.
*The TGA considers cleaning agents that contain levels of benzalkonium chloride below 5-10% are safe to use on medical devices. Disinfectants generally use about 0.5% benzalkonium chloride, which is considered noncorrosive at these levels.
ii. Detergent wipes used by the hospital to clean the pumps contained the ingredient ‘benzalkonium chloride’. This is classed as a quaternary ammonium compound which is a corrosive ingredient and therefore should not be used**.
** Benzalkonium chloride is unsafe at a concentration above 10% and therefore should not be used without being diluted.
iii. When cleaning medical devices the TGA recommends that health facilities:
• Review all decontamination processes that use a disinfectant wipe or detergent containing quaternary ammonium compounds on a plastic surface***.
*** Particularly if the surface is made of polycarbonate material.
GAMA Healthcare Ltd. would like to confirm to all our customers that Clinell Universal Wipes contain benzalkonium chloride at a concentration of less than 0.5% and therefore per the TGA clarification are considered non-corrosive at this level.
We have also been advised that the wording of the alert specifically referencing detergent wipes has been interpreted to mean neutral detergent wipes. GAMA Healthcare would like to confirm Clinell Detergent wipes do not contain benzalkonium chloride.
We fully support the TGA statement that equipment manufacturers’ cleaning recommendations should be followed.
GAMA Healthcare continues to work with equipment manufacturers on material compatibility and welcomes the opportunity to collaborate on any items which require disinfection and are not currently listed on our approved equipment list.
For guidance of on using disinfectant wipes, please download the Instructions For Use below.
Statement Instructions For Use
The Sunday Times HSBC International Track 200 ranks Britain’s mid-market private companies with the fastest-growing international sales, measured over their latest two years of available accounts.
This is the 8th year of The Sunday Times HSBC International Track 200, the league table of Britain’s mid-market private companies with the fastest-growing international sales. The International Track 200 ranks the 200 mid-market companies (25m+ total sales) based on their growth in international sales over the last two years of available data; whereas our SME Export Track 100 ranks companies with sales of less than 25m. Despite the backdrop of volatile international markets and the prospect of the UK leaving the EU, this year’s league table findings indicate the breadth of UK companies still making remarkable headway overseas.
GAMA Healthcare is delighted to make its debut entry this year at number 98 with a 41.91% increase in international sales over the last 2 years.
[17th May 2017, WATFORD, UK] Leading infection control specialists, GAMA Healthcare Ltd, acquires the Clinell division of their Australian distributor, AMCLA Pty Ltd., in Victoria. This significant investment demonstrates GAMA’s continued commitment to infection prevention – providing outstanding education, training and clinical support to healthcare professionals across the world.
Plans for growth, support and education
GAMA will take over the current office in Mornington, Victoria and will retain all AMCLA personnel. The business unveils ambitious investment plans to emulate success in the UK – aiming to double the current workforce over the next twelve months. With headquarters in Watford, England, GAMA now has offices in six cities, across three continents.
“This is a very exciting time for us, as we enhance our service in Australia”, says Dr Guy Braverman, Managing Director and Co-Founder of GAMA. “As world leaders in infection prevention we are committed to empowering healthcare professionals to make the right choices to achieve the best clinical outcomes. Through our growing team of experienced clinical nurse trainers and area managers, we can increase support and after-sales service to meet the individual needs of
In the UK, GAMA provides bespoke, local training through group sessions, ward-based training and practitioner meetings – delivered by a team of infection control specialists. “Our organisational support training programme is valued very highly by our UK customers and we look forward to implementing this in Australia,” says Dr Martin Kiernan, Clinical Director at GAMA. “We have developed the most advanced and fully customisable tablet-based training suite that is free to all customers. In the last six months of 2016, we hosted over 250 training days. This support has been critical in developing new business opportunities and retaining key contracts.“
Commitment to products, people and partnerships
Founded in 2004 by two medical doctors, GAMA Healthcare has become a world leading developer and manufacturer of infection prevention technology. The Clinell range is the NHS’s number 1 brand, providing a range of product lines for surface care, hygiene monitoring, and patient skincare. GAMA’s dedication to infection prevention is demonstrated through both product innovation and continued investment in people and partnerships.
For all media enquiries and interview requests please contact Beth Lowes at ROAD Communications on: email@example.com or call +44(0)208 995 5832.
About GAMA Healthcare
Formed in 2004 by two medical doctors, GAMA Healthcare is a world leading developer and manufacturer of infection prevention products for the healthcare sector. Their focus remains on quality, innovation and continual improvement. We work closely with our customers, identifying their needs and providing solutions to real problems. Our new and continually evolving product lines – specialising in surface care, hygiene monitoring, patient skin care and easyclean computer accessories – offer market leading solutions to infection control problems found throughout healthcare provision.
GAMA Healthcare products are marketed under the brands Clinell, Carell and Cleanall and are widely used in many hospitals in around the worldwide. In the last 13 years, they have become the largest supplier of wet and dry wipes in the United Kingdom, with at least one of their products used in every National Health Service hospital. They distribute to over 60 countries around the world and the list continues to grow.
Since 2007, AMCLA – a family owned specialist import and distribution company, have brought world class healthcare delivery solutions through their two key sales divisions: medical and pharmaceutical. AMCLA have built a reputation for supplying innovative, high quality products to healthcare markets.